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Abstract 
Background: Spinal anesthesia is a commonly used technique the world over. It is very easy to perform and has 
the potential to provide excellent operating conditions for the surgery. This study was conducting in Department 
of anesthesiology and pain medicine, Combined Military Hospital Malir Cantt Karachi from 1st September to 31st 
December 2017. The aim of the study is to compare the effectiveness of tramadol vs pethidine for treatment of 
shivering occurring after spinal anesthesia by using Double blind comparative study.. 
Methods: 70 patients were selected following non-random convenient sampling and were divided into Group A 
and B. Group A received 0.25mg/kg tramadol while Group B received 0.35mg/kg pethidine. Time to complete 
control of shivering was noted. Nausea and vomiting were also evaluated by using a four-point scale (Table1). 
Results: Shivering was successfully controlled in 91.4% and 85.7% respectively in group A and B; success rates 
were not statistically different (p=0.23). Average time between injection tramadol to complete control of shivering 
in successfully treated Group A patients was 210±63 seconds (range of 100 to 310 seconds) and for pethidine 
average time was 174±52 seconds (range of 90 to 258 seconds). Pethidine showed a shorter time to control 
shivering which was statistically significant (p=0.09) but in real time amounted to an average of 0.6 minutes 
(Figure 2). Nausea and vomiting were more frequent (14.3% vs 8.6%) in group B as compared to Group A and this 
was statistically significant (p=0.03). 
Conclusion: Tramadol was found to be as effective as pethidine in controlling shivering with fewer side effects in 
spinal anesthesia 
Keywords: Tramadol, Pethidine, Spinal Anesthesia.  
 
 
 
Introduction 
Spinal anesthesia is a commonly used technique the 
world over. It is very easy to perform and has the 
potential to provide excellent operating conditions for 
the surgery.  
There are many advantages of spinal anesthesia as 
compared to the general anesthesia. They include low 
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cost, fewer adverse effects on respiration, reduced risk 
of airway obstruction or aspiration, excellent muscle 
relaxation for lower abdominal or lower limb surgery, 
less blood loss as compared to when the same 
operation is done under general anesthesia etc. 
However spinal anesthesia does have certain 
shortcomings. Few of the include hypotension, high 
neural blockade, urinary retention, post dural 
puncture headache. 
One of the problems arising during spinal anesthesia is 
shivering which may quite distressful for the patient, 
which include increased oxygen consumption, 
increased carbon dioxide production, increased lung 
ventilation and cardiac output, and decreased mixed 
venous oxygen saturation. It has been shown to 
increase metabolic rate by up to 400%1, 2. 
When the core body temperature drops, the 
shivering reflex is triggered to maintain homeostasis. 
Skeletal muscles begin to shake in small movements, 
creating warmth by expending energy. In most of the 
cases shivering can be prevented and controlled by 
maintaining ambient temperature, using warm 
blankets, head wraps, administering warm 
intravenous fluids, using fluid warmers. 
Pharmacological control of shivering however is an 
effective alternate modality. Various drugs have been 
used for control of per-operative and post-operative 
shivering including morphine, pethidine, tramadol3, 
clonidine4, nefopam5, and doxapram6. It has been 
reported that tramadol and pethidine were more 
effective in controlling post operative shivering7, 8, 9. 
For the control of shivering during anesthesia 
minimum effective dose for pethidine has been 
reported to be 0.35 mg/kg body weight6. Tramadol, on 
the other hand modulates central monoaminergic 
pathways, inhibiting the neuronal uptake of 
norepinephrine and serotonin10. It is a centrally acting 
analgesic drug with weak opioid agonist properties 
and is also effective in the treatment of postoperative 
shivering11. The minimum dosage used for the 
treatment of shivering has been reported as 
0.25mg/kg12. 
This study was carried out to compare the two most 
commonly used drugs to treat shivering during spinal 
anesthesia. 
 
Materials and Methods 
A double blind comparative study was conducted 
from 1st September 2017 to 31st December 2017 at 
Combined Military Hospital Malir Cantt Karachi, 
Pakistan. After institutional committee approval and 
written informed consent, a total of 70 patients of ASA 
physical status I and II, aged between 25 to 35 year 
who developed shivering under spinal anesthesia 
were selected by non-random convenient sampling. 
They were divided and group A and B each 
comprising of 35 patients. Patients with physical status 
above ASA II, any contraindication to spinal 
anesthesia, tramadol, pethidine, patients with body 
temperature above 38 oC, patients with history of 
taking anti-depressants, alcohol or illicit drugs were 
excluded. 
Group A patients were given tramadol 0.25 mg/kg 
over 30 seconds when they developed shivering. 
Group B patients were given pethidine 0.35 mg/ kg 
over 30 seconds when they developed shivering. The 
operating room temperature was kept between 24oC to 
28 oC. All infused fluids ad drugs were given at room 
temperature. 
Data was recorded on a specified Performa. The 
standard monitoring was used including 
electrocardiography, pulseoximetry, non-invasive 
blood pressure and heart rate. The time of onset of 
shivering relative to the duration of anesthesia and the 
time of injection were noted. Time to complete control 
of shivering was also noted. Nausea and vomiting 
were evaluated by using a four point scale. If patients 
developed severe nausea or vomiting metoclopramide 
10mg was administered intravenously. 
Univariate analysis was done and P-values using 
student t-test, z-test and F-test to find out the strength 
of the association between the variables. Fisher Exact 
Probability test was used for nominal data. Correlation 
between variables was studied using Regression 
analysis. The statistical analysis was done on SPSS v21 
and Microsoft excel. P value less than 0.05 was 
considered significant. 
Result 
 
A total of seventy patients of both sexes who 
developed severe shivering i-e grade 3 or 4 on a 0-4 
point scale (Table 3), during spinal anesthesia were 
included in the study. There were 27 female and 43 
males (38.6% and 61.4%). Their ages ranged 20 to 65 
years, mean age 40.0±13.8 years. The patients were 
divided in two groups for the interventional study. 
Group A included 35 patients who received I.V 
tramadol 0.35 mg/kg body weight for the treatment of 
shivering during spinal anesthesia. Group B included 
35 patients who received I.V tramadol 0.25 mg/kg for 
the treatment of shivering during spinal anesthesia. 
In Group A there were 14 females and 21 males, with 
age range between 20 to 65 years, mean age of 
41.1±14.0 years, with a mean weight of 62.7±10 kg. In 
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Group B there were 13 females and 22 males, with age 
range between 20 to 64 years, mean age of 39.0±13.4 
years weighing on an average 63.8±11.2 kg. 
Total duration of anesthesia ranged between 25-120 
minutes in Group A patients with an average of 75±34 
minutes. In Group B patients the total duration of 
anesthesia ranged between 30-135 minutes with an 
average of 85±35 minutes. Time between induction of 
spinal anesthesia and onset of shivering for Group A 
ranged from 9.30 to 56.10 minutes with an average 
interval of 28.30±12.00 minutes. In Group B the time 
between induction of anesthesia and onset of shivering 
ranged between 11.00 to 59.30 minutes. The time 
interval before onset of shivering for all patients was 
9.30 to 59.30 minutes with an average time interval of 
28.50±11.50 minutes. 
Shivering was successfully controlled in 32 out of 35 
patients of Group A and 30 out of 35 patients of Group 
B, showing success rate of 91.4% and 85.7% of 
tramadol and pethidine respectively. 
 
Table 1: Nausea vomiting evaluation 4 point scale 
Score Nausea Vomiting 
0 No nausea No vomiting 
1 Once Once 
2 Twice Twice 
3 Three or more times Three or more 
times 
 
Table 2: Summary of Patient characteristics 
Tramadol (n=35) Pethidine 
(n=35) 
Gender 
Female 
Male 
 
14 
21 
 
13 
22 
Age (yr) 41.1± 14.0 39±13.4 
Weight (Kg) 62.7±10 53.8±11.2 
ASA 
Class I 
Class II 
 
16 
21 
 
20 
15 
Total duration of 
anesthesia (min) 
75±34 84.7±35 
Time to onset of 
shivering (min.sec) 
28.30±12.00 29.30±12.30 
Shivering grade before 
treatment 
Grade 3 
Grade 4 
 
21 
14 
 
19 
16 
Time to control shivering 
(sec) 
210±63 174±52 
Time between injection of tramadol to complete 
control of shivering in successfully treated Group A 
patients was observed to range from 100 to 310 
seconds, with an average time of 210±63 seconds. Time 
taken for female patients to respond was 199±72 
seconds and for males it was 216±53 seconds. In Group 
B patients the time between injection of pethidine to 
complete control of shivering was observed to range 
from 90 to 258 seconds, with an average time of 174±52 
seconds in successfully treated subjects. The time 
taken for female patients to respond was 157±58 
seconds and for males it was 184±46 seconds. 
In this study we also noted down the severity of 
nausea and vomiting (Table 1). Group A who received 
injection tramadol, two patients complained of mild 
nausea (grade 1) and one complained of severe nausea 
(grade 2) and no patient vomited, a total of three 
patients complaining of this side effect (8.6%, 4 grade 
points). In Group B who received injection pethidine, 
two patients complained of mild nausea (grade 1) and 
one patient had severe nausea (grade 2) and one 
vomited (grade 3), a total of five patients complaining 
this side effect (14.3%, 11 grade points). 
The nominal data was analyzed using Fisher Exact 
Probability Test. The calculated probability was 0.23. 
Hence the difference between the success rates of 
tramadol and pethidine to control shivering was not 
statistically significant at a p-value of 0.05. The 
statistical analysis using Students t-Test showed a 
statistically significant difference between the times 
taken by tramadol and by pethidine to control 
shivering (p value of 0.009331). Similarly z-test for two 
samples means analysis on the same data also showed 
statistically significant difference between the times 
taken by tramadol and by pethidine to control 
shivering (p value of 0.007488). 
Statistical analysis using Student t-Test failed to show 
and statistically significant difference between the time 
taken by tramadol to control shivering in female and 
male patients at p value of 0.05(p value of 0.244387). 
Similarly z-test for two sample means analysis on the 
same data also failed to show a statistically significant 
difference between the times taken by tramadol to 
control shivering in female and male patients at p 
value of 0.05 (p value of 0.240104). 
 
Table 3: Shivering evaluation 4 point scale 
Score Type of shivering Location 
0 None No shivering detected 
1 Patient feeling cold 
but no shivering 
No shivering detected 
2 Mild Shivering localized to neck 
and thorax  
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3 Moderate Shivering involves gross 
movement of upper 
extremities in addition to 
neck and thorax 
4 Severe Shivering involves gross 
movement of the trunk and 
upper and lower 
extremities 
 
Statistical analysis using Students t-Test failed to show 
any statistically significant difference between the 
times taken by pethidine to control shivering in female 
and male patients at p value of 0.05 (p value of 0.100). 
Similarly z-test for two sample means analysis on the 
same data failed to show a statistically significant 
difference between the times taken by tramadol to 
control shivering in female and male patients at p 
value of 0.05 (p value 0.240104). 
 
Discussion 
A total of seventy patients of both sexes who 
developed severe shivering i-e grade 3 or 4 on a 0-4 
point scale (Table 3), during spinal anesthesia were 
included in the study. There were 27 female and 43 
males (38.6% and 61.4%). Their ages ranged 20 to 65 
years, mean age 40.0±13.8 years. The patients were 
divided in two groups for the interventional study. 
Group A included 35 patients who received I.V 
tramadol 0.35 mg/kg body weight for the treatment of 
shivering during spinal anesthesia. Group B included 
35 patients who received I.V tramadol 0.25 mg/kg for 
the treatment of shivering during spinal anesthesia. 
In Group A there were 14 females and 21 males, with 
age range between 20 to 65 years, mean age of 
41.1±14.0 years, with a mean weight of 62.7±10 kg. In 
Group B there were 13 females and 22 males, with age 
range between 20 to 64 years, mean age of 39.0±13.4 
years weighing on an average 63.8±11.2 kg. 
Total duration of anesthesia ranged between 25-120 
minutes in Group A patients with an average of 75±34 
minutes. In Group B patients the total duration of 
anesthesia ranged between 30-135 minutes with an 
average of 85±35 minutes. Time between induction of 
spinal anesthesia and onset of shivering for Group A 
ranged from 9.30 to 56.10 minutes with an average 
interval of 28.30±12.00 minutes. In Group B the time 
between induction of anesthesia and onset of shivering 
ranged between 11.00 to 59.30 minutes. The time 
interval before onset of shivering for all patients was 
9.30 to 59.30 minutes with an average time interval of 
28.50±11.50 minutes. Shivering was successfully 
controlled in 32 out of 35 patients of Group A and 30 
out of 35 patients of Group B, showing success rate of 
91.4% and 85.7% of tramadol and pethidine 
respectively. 
Time between injections of tramadol to complete 
control of shivering in successfully treated Group A 
patients was observed to range from 100 to 310 
seconds, with an average time of 210±63 seconds. Time 
taken for female patients to respond was 199±72 
seconds and for males it was 216±53 seconds. In Group 
B patients the time between injections of pethidine to 
complete control of shivering was observed to range 
from 90 to 258 seconds, with an average time of 174±52 
seconds in successfully treated subjects. The time 
taken for female patients to respond was 157±58 
seconds and for males it was 184±46 seconds. 
In this study we also noted down the severity of 
nausea and vomiting (Table 1). Group A who received 
injection tramadol, two patients complained of mild 
nausea (grade 1) and one complained of severe nausea 
(grade 2) and no patient vomited, a total of three 
patients complaining of this side effect(8.6%, 4 grade 
points). In Group B who received injection pethidine, 
two patients complained of mild nausea (grade 1) and 
one patient had severe nausea ( grade 2) and one 
vomited (grade 3), a total of five patients complaining 
this side effect (14.3%, 11 grade points). 
The nominal data was analyzed using Fisher Exact 
Probability Test. The calculated probability was 0.23. 
Hence the difference between the success rates of 
tramadol and pethidine to control shivering was not 
statistically significant at a p-value of 0.05. The 
statistical analysis using Students t-Test showed a 
statistically significant difference between the times 
taken by tramadol and by pethidine to control 
shivering (p value of 0.009331). Similarly z-test for two 
samples means analysis on the same data also showed 
statistically significant difference between the times 
taken by tramadol and by pethidine to control 
shivering (p value of 0.007488). 
Statistical analysis using Student t-Test failed to show 
and statistically significant difference between the time 
taken by tramadol to control shivering in female and 
male patients at p value of 0.05(p value of 0.244387). 
Similarly z-test for two sample means analysis on the 
same data also failed to show a statistically significant 
difference between the times taken by tramadol to 
control shivering in female and male patients at p 
value of 0.05 (p value of 0.240104). 
Statistical analysis using Students t-Test failed to show 
any statistically significant difference between the 
times taken by pethidine to control shivering in female 
and male patients at p value of 0.05 (p value of 0.100). 
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Similarly z-test for two sample means analysis on the 
same data failed to show a statistically significant 
difference between the times taken by tramadol to 
control shivering in female and male patients at p 
value of 0.05 (p value 0.240104). 
 
Conclusion 
On the basis of this study we concluded that Both 
tramadol and pethidine exhibited a high success rate 
for controlling shivering during spinal anesthesia, with 
no statistically significant difference between the two 
success rates. Pethidine showed a shorter time to 
control shivering during spinal anesthesia as 
compared to tramadol. This was statistically 
significant, but in real time the difference was 0.6 
minutes. With pethidine the incidence and severity of 
side effects of nausea and vomiting was somewhat 
higher that with tramadol, and this difference was 
statistically significant. Tramadol is cheap and readily 
available, unlike pethidine which is a controlled drug. 
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